Alliance Pharma has seen profits and sales double after it acquired a range of products from rival Alliance Pharma The current year . Sales rose by 102% to £97.5mln while profits were up by a similar amount to £22.2mln, with cash flow also strong. The firm's sales rose to $121.3m ( £97.5m ), a 102% increase, with profits rising to £97.5m . Alliance will now focus on developing three of its core brands — Kelo-cote , MacuShield and Diclectin — on an international level, according to Chairman Andrew Smith .
Alliance Pharma has seen profits and sales double after it acquired a range of products from rival Alliance Pharma The current year . The firm's sales rose to $121.3m ( £97.5m ), a 102% increase, with profits rising to £97.5m . Alliance will now focus on developing three of its core brands — Kelo-cote , MacuShield and Diclectin — on an international level, according to Chairman Andrew Smith .